Fogarty International Center; Notice of Meeting, 6402-6403 [2010-2559]

Download as PDF 6402 Federal Register / Vol. 75, No. 26 / Tuesday, February 9, 2010 / Notices II. Electronic Access Persons with access to the Internet may obtain the documents at https:// www.fda.gov/BiologicsBloodVaccines/ BloodBloodProducts/Approved Products/PremarketApprovalsPMAs/ ucm185249.htm Dated: February 4, 2010. Leslie Kux, Acting Assistant Commissioner for Policy. [FR Doc. 2010–2757 Filed 2–8–10; 8:45 am] BILLING CODE 4160–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Board of Scientific Counselors, National Center for Health Marketing (BSC, NCHM) Cprice-sewell on DSK2BSOYB1PROD with NOTICES In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), and pursuant to the requirements of 42 CFR 83.15(a), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned committee: Times and Dates: 9 a.m.–5 p.m., February 25, 2010. 8:30 a.m.–1 p.m., February 26, 2010. Place: CDC, 2400 Century Parkway, Building 2400, Room 1A (1023), Atlanta, Georgia 30345. Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 60 people. The toll free dial-in number is 1 (877) 617–5977 with a pass code of 3468113. Purpose: The Secretary, Department of Health and Human Services (HHS), and, by delegation, the Director, CDC, are authorized under Section 301 (42 U.S.C. 241) and Section 311 (42 U.S.C. 243) of the Public Health Service Act (PHSA), as amended to: Develop and implement disease prevention and control, environmental health, and health promotion and health education activities designed to improve the health of the people of the United States. Under these and additional PHSA and other authorities, CDC acts by identifying and defining preventable health problems, maintaining active surveillance of diseases through epidemiologic and laboratory investigations and data collection, analysis, and distribution; conducting operational research aimed at developing and testing effective disease prevention, control, and health promotion programs; administering a national occupational safety and health program; controlling the introduction and spread of infectious diseases, and providing consultation and assistance to other nations and international agencies to assist in improving their disease prevention and control, environmental health, and health promotion activities. CDC carries out these VerDate Nov<24>2008 14:39 Feb 08, 2010 Jkt 220001 functions through a number of National Centers, Institutes and Offices with expertise and responsibilities in specific areas. Matters To Be Discussed: The agenda will include: A discussion of the recent organizational changes at CDC, specifically presentations on the vision, mission, goals and organizational structure of the new Office of Communications; discussions on program activities, including scientific programs, that will enable the board to provide recommendations and advice on the future course for health communications and marketing at CDC; and a discussion of focus areas and new ideas to implement and expand health marketing science at CDC. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Dionne R. Mason, Committee Management Specialist, NCHM, CDC, 1600 Clifton Road, NE., Mail Stop E–21, Atlanta, Georgia 30333; Telephone: (404) 498–2314, Fax (404) 498– 2221; E-mail: zsu0@cdc.gov. The deadline for notification of attendance is February 17, 2010. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register Notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. application of new technologies; and reviews the extent to which progress has been made toward eliminating tuberculosis. Matters To Be Discussed: Agenda items include issues pertaining to regionalization of tuberculosis care; the role of genetics in tuberculosis; tuberculosis control updates from the U.S. affiliated Pacific Islands; tuberculosis research updates; and other related tuberculosis issues. Agenda items are subject to change as priorities dictate. For More Information Contact: Margie Scott-Cseh, CDC, 1600 Clifton Road, NE., Mail Stop E–07, Atlanta, Georgia 30333, telephone (404) 639–8317. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register Notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: February 1, 2010. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2010–2766 Filed 2–8–10; 8:45 am] Fogarty International Center; Notice of Meeting BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Council for the Elimination of Tuberculosis (ACET) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned committee: Times and Dates: 8:30 a.m.–5:30 p.m., March 2, 2010. 8:30 a.m.–2:30 p.m., March 3, 2010. Place: CDC, Corporate Square, Building 8, 1st Floor Conference Room, Atlanta, Georgia 30333, telephone (404) 639–8317. Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 100 people. Purpose: This council advises and makes recommendations to the Secretary of Health and Human Services, the Assistant Secretary for Health, and the Director, CDC, regarding the elimination of tuberculosis. Specifically, the Council makes recommendations regarding policies, strategies, objectives, and priorities; addresses the development and PO 00000 Frm 00062 Fmt 4703 Sfmt 4703 Dated: February 1, 2010. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2010–2768 Filed 2–8–10; 8:45 am] BILLING CODE 4163–18–P National Institutes of Health Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the Fogarty International Center Advisory Board. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Fogarty International Center Advisory Board. E:\FR\FM\09FEN1.SGM 09FEN1 Federal Register / Vol. 75, No. 26 / Tuesday, February 9, 2010 / Notices Cprice-sewell on DSK2BSOYB1PROD with NOTICES Date: February 9, 2010. Closed: 8:30 a.m. to 12 p.m. Agenda: To review and evaluate grant applications and/or proposals. Place: National Institutes of Health, Lawton Chiles International House, Bethesda, MD 20892. Open: 12 p.m. to 3:30 p.m. Agenda: A report of the FIC Director on updates and overviews of new FIC initiatives. Topics to be discussed: New Developments in Chronic Disease Research and Training. Place: National Institutes of Health, Lawton Chiles International House, Bethesda, MD 20892. Contact Person: Robert Eiss, Public Health Advisor, Fogarty International Center, National Institutes of Health, 31 Center Drive, Room B2C02, Bethesda, MD 20892.(301) 496–1415. eissr@mail.nih.gov. This meeting is being published less than 15 days prior to the meeting due to timing limitations imposed by administrative matters. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, drivers license, or passport) and to state the purpose of their visit. Information is also available on the Institutes/Center’s home page: https:// www.nih.gov/fic/about/advisory.html, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.106, Minority International Research Training Grant in the Biomedical and Behavioral Sciences; 93.154, Special International Postdoctoral Research Program in Acquired Immunodeficiency Syndrome; 93.168, International Cooperative Biodiversity Groups Program; 93.934, Fogarty International Research Collaboration Award; 93.989, Senior International Fellowship Awards Program, National Institutes of Health, HHS) Dated: February 1, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–2559 Filed 2–8–10; 8:45 am] BILLING CODE 4140–01–M VerDate Nov<24>2008 14:39 Feb 08, 2010 Jkt 220001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National Center for Health Statistics (NCHS), Classifications and Public Health Data Standards Staff, announces the following meeting: Name: ICD–9–CM Coordination and Maintenance Committee meeting. Time and Date: 9 a.m.–4:30 p.m., March 9–10, 2010. Place: Centers for Medicare and Medicaid Services (CMS) Auditorium, 7500 Security Boulevard, Baltimore, Maryland. Status: Open to the public. Purpose: The ICD–9–CM Coordination and Maintenance (C&M) Committee will hold its first meeting of the 2010 calendar year cycle on Tuesday and Wednesday March 9–10, 2010. The C&M meeting is a public forum for the presentation of proposed modifications to the International Classification of Diseases, Ninth-Revision, Clinical Modification. Matters to be Discussed: Tentative agenda items include: March 9, 2010: ICD–10 updates: GEMs; Freeze update; ICD–10–CM/ICD–10–PCS updates Application of Collagen Based Tissue Sealant Patches Biopsy of Soft Tissue Mass Central Venous Catheter Placement Using Intra-Atrial Electrocardiographic Guidance Circulating Tumor Cell Enumeration, Magnetic Closed Chest Intra-cardiac Mitral Valve Repair Continuous Glucose Monitoring Fat Graft to Breast Insertion of Intracranial Neurostimulator Lead(s) Internal Fixation of Sternum Intralaminar Lumbar Decompression and Laminotomy with Epidurography Intra-operative Fluorescence Vascular Angiography (IFVA) Laparoscopic Hernia Repair without Mesh Thoracoscopic Cardiac Ablation Addenda (procedures) March 10, 2010: Acquired absence of joint Brain death Eaton-Lambert Syndrome E. coli infection Fluency disorders (stuttering) Glaucoma staging H1N1 (Swine flu) Transfusion transmitted infections PO 00000 Frm 00063 Fmt 4703 Sfmt 4703 6403 Uranium exposure Addenda (diagnoses) Contact Person for Additional Information: Amy Blum, Medical Systems Specialist, Classifications and Public Health Data Standards Staff, NCHS, 3311 Toledo Road, Room 2402, Hyattsville, Maryland 20782, e-mail alb8@cdc.gov, telephone 301–458–4106 (diagnosis), Mady Hue, Health Insurance Specialist, Division of Acute Care, CMS, 7500 Security Blvd., Baltimore, Maryland 21244, e-mail marilu.hue@cms.hhs.gov, telephone 410–786–4510 (procedures). Note: CMS and NCHS will no longer be providing paper copies of handouts for the meeting. Electronic copies of all meeting materials will be posted on the CMS and NCHS Web sites prior to the meeting at https://www.cms.hhs.gov/ ICD9ProviderDiagnosticCodes/ 03_meetings.asp#TopOfPage and https:// www.cdc.gov/nchs/icd/ icd9cm_maintenance.htm. Notice: Because of increased security requirements CMS has instituted stringent procedures for entrance into the building by non-government employees. Persons without a government I.D. will need to show an official form of picture I.D., (such as a drivers license), and sign-in at the security desk upon entering the building. Those who wish to attend a specific ICD–9–CM C&M meeting in the CMS auditorium must submit their name and organization for addition to the meeting visitor list. Those wishing to attend the March 9–10, 2010 meeting must submit their name and organization by March 5, 2010 for inclusion on the visitor list. This visitor list will be maintained at the front desk of the CMS building and used by the guards to admit visitors to the meeting. Those who attended previous ICD–9–CM C&M meetings will no longer be automatically added to the visitor list. You must request inclusion of your name prior to each meeting you attend. Register to attend the meeting on-line at: https://www.cms.hhs.gov/ apps/events/. Notice: This is a public meeting. However, because of fire code requirements, should the number of attendants meet the capacity of the room, the meeting will be closed. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. E:\FR\FM\09FEN1.SGM 09FEN1

Agencies

[Federal Register Volume 75, Number 26 (Tuesday, February 9, 2010)]
[Notices]
[Pages 6402-6403]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-2559]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Fogarty International Center; Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a meeting of the 
Fogarty International Center Advisory Board.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and/or contract proposals 
and the discussions could disclose confidential trade secrets or 
commercial property such as patentable material, and personal 
information concerning individuals associated with the grant 
applications and/or contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Fogarty International Center Advisory Board.

[[Page 6403]]

    Date: February 9, 2010.
    Closed: 8:30 a.m. to 12 p.m.
    Agenda: To review and evaluate grant applications and/or 
proposals.
    Place: National Institutes of Health, Lawton Chiles 
International House, Bethesda, MD 20892.
    Open: 12 p.m. to 3:30 p.m.
    Agenda: A report of the FIC Director on updates and overviews of 
new FIC initiatives. Topics to be discussed: New Developments in 
Chronic Disease Research and Training.
    Place: National Institutes of Health, Lawton Chiles 
International House, Bethesda, MD 20892.
    Contact Person: Robert Eiss, Public Health Advisor, Fogarty 
International Center, National Institutes of Health, 31 Center 
Drive, Room B2C02, Bethesda, MD 20892.(301) 496-1415. 
eissr@mail.nih.gov.
    This meeting is being published less than 15 days prior to the 
meeting due to timing limitations imposed by administrative matters.
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NIH campus. All visitor vehicles, 
including taxicabs, hotel, and airport shuttles will be inspected 
before being allowed on campus. Visitors will be asked to show one 
form of identification (for example, a government-issued photo ID, 
drivers license, or passport) and to state the purpose of their 
visit.
    Information is also available on the Institutes/Center's home 
page: https://www.nih.gov/fic/about/advisory.html, where an agenda 
and any additional information for the meeting will be posted when 
available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.106, 
Minority International Research Training Grant in the Biomedical and 
Behavioral Sciences; 93.154, Special International Postdoctoral 
Research Program in Acquired Immunodeficiency Syndrome; 93.168, 
International Cooperative Biodiversity Groups Program; 93.934, 
Fogarty International Research Collaboration Award; 93.989, Senior 
International Fellowship Awards Program, National Institutes of 
Health, HHS)

    Dated: February 1, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-2559 Filed 2-8-10; 8:45 am]
BILLING CODE 4140-01-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.